- Mahdavi S, Palatini P, El-Sohemy A. CYP1A2 Genetic Variation, Coffee Intake, and Kidney Dysfunction. JAMA Netw Open. 2023 Jan 3;6(1):e2247868. doi: 10.1001/jamanetworkopen.2022.47868. PMID: 36701157.
CYP1A2 takes over the detoxification of caffeine in the human body. There are different genotypes that control the speed of this metabolism:
People with the AC and CC variants are considered slow metabolisers of caffeine.
The data were taken from the Italian Hypertension and Ambulatory Recording Venetia Study (HARVEST), whose cohort included people with grade 1 hypertension and a study period of more than 16 years.
Sufficient information on coffee consumption, CYP1A2 genotype, and urine samples was available from 604 participants, hence these were evaluated in the current study.
In the study, renal dysfunction was defined as
Coffee consumption was divided into:
In addition, the CYP1A2 genotype was determined and blood pressure was checked regularly. The genotype distribution was approximately equal across all three coffee consumption groups.
The data showed that for the cohort as a whole or the fast-metabolizers, coffee consumption was irrelevant for the risk of developing renal dysfunction or hypertension.
However, for the slow-metabolizers, those with genotype AC or CC, there was a significantly increased risk of albuminuria, hyperfiltration and hypertension - if they consumed more than three cups of coffee per day.
The study showed that increased coffee consumption can indeed be harmful to the kidneys. However, this only seems to apply to people who are susceptible, due to the genetic variation in CYP1A2.
* Slow- as opposed to fast-metabolisers (slow or fast metabolisers).